| Literature DB >> 35052975 |
Ingrid Christensen1,2, Jon Birger Haug1, Dag Berild3,4, Jørgen Vildershøj Bjørnholt4,5, Brita Skodvin6, Lars-Petter Jelsness-Jørgensen1,7.
Abstract
Antimicrobial resistance (AMR) is a threat to hospital patients. Antimicrobial stewardship programs (ASPs) can counteract AMR. To optimize ASPs, we need to understand what affects physicians' antibiotic prescription from several contexts. In this study, we aimed to explore the factors affecting hospital physicians' antibiotic choices in a low-resistance country to identify potential targets for future ASPs. We interviewed 14 physicians involved in antibiotic prescription in a Norwegian hospital. The interviews were audiotaped, transcribed verbatim, and analyzed using thematic analysis. The main factors affecting antibiotic prescription were a high work pressure, insufficient staff resources, and uncertainties regarding clinical decisions. Treatment expectations from patients and next of kin, benevolence towards the patients, suboptimal microbiological testing, and limited time for infectious disease specialists to offer advisory services also affected the antibiotic choices. Future ASP efforts should evaluate the system organization and prioritizations to address and manage potential time-pressure issues. To limit the use of broad-spectrum antibiotics, improving microbiology testing and the routines for consultations with infectious disease specialists seems beneficial. We also identified a need among the prescribing physicians for a debate on ethical antibiotic questions.Entities:
Keywords: antibiotic prescription; antibiotic stewardship; antimicrobial resistance; hospital physicians; low-resistance country; qualitative study; semi-structured interviews
Year: 2022 PMID: 35052975 PMCID: PMC8773165 DOI: 10.3390/antibiotics11010098
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382
Characteristics of the study participants (n = 14).
|
|
|
| Median (IQR) | 36.5 (14.5) |
| Range | 29–66 |
|
|
|
| <5 years | 4 |
| 5–10 years | 3 |
| 10–20 years | 4 |
| >20 years | 3 |
|
|
|
| Female | 9 |
| Male | 5 |
IQR: Interquartile range.
Figure 1Visualization of the main themes (in the circle) with the consisting subthemes (squares).
Themes, subthemes, and illustrative quotes representing the determinants of antibiotic prescription.
| Theme | Subtheme | Quotes (Respondent Number, Years of Experience) |
|---|---|---|
| Clinical workflow pressures | Time pressure | There is too much pressure, no time to just observe the patient (…) so most doctors will give what they know works, which means broad-spectrum antibiotics, and the problem is that it works! (…) (R4, 25 years) |
| Follow-up resources | If you know the patient gets followed up, and clinical deterioration would easily get picked up, you would probably be more comfortable starting penicillin (instead of more broad-spectrum antibiotics), as opposed to a patient who gets left alone in a corridor, which is often the case (R9, 8 years) | |
| Clinical uncertainty | Just in case | 9/10 doctors would, in cases of insecurity, rather ensure themselves (and give broad-spectrum antibiotics) (R9, 8 years) |
| Knowledge and experience | It is an intuition you get with clinical experience that allowed us to trust the clinical picture and withhold antibiotics (R6, 4 years) | |
| Decision support | Microbiological tests | The most important thing is to have a resistance pattern, then I can feel safe that I use the right antibiotic (and don’t need to give more broad-spectrum antibiotics) (R5, 4 years) |
| Collegial consulting | We often call up infectious medicine and ask for help (…) if we are in doubt. (R14, 1 years) | |
| Benevolence | The patient’s wellbeing | If you’ve got an, e.g., immunosuppressed patient who is ill, then we treat with what is available in antibiotics now without worrying about the problem of resistance, sure we do (R10, 16 years) |
| Treatment expectations | In cancer and transplant patients, we often choose more broad-spectrum antibiotics, as they are immunocompromised, though you know broader spectrum means more resistance (…), and that is problematic, because patients who could have been cured from cancer could later die due the complications of the treatment (multi-resistant bacteria) (R10, 8 years) |
Summarized interview guide (full version in Supplementary Materials File S1).
| 1 | What are your thoughts about rational antibiotic prescription? |
| 2 | What are your thoughts about antimicrobial resistance? |
| 3 | How would you describe the antibiotic prescription in this hospital, from your perspective? |
| 4 | What influences you when you prescribe antibiotics? |
| 5 | Can you please tell me about a situation where you had to decide when to start, not start, or stop antibiotics that you remember in particular? |
| 6 | Do you have any final comments on rational antibiotic prescription? |